Australian Life Sciences Stock News

RBC Capital Markets recently initiated coverage of SGH Ltd with an outperform rating, highlighting the company’s 15.5% interest in the Crux gas project in Western Australia, a joint venture with Shell that is planned to start production in the late 2020s. The report brought fresh attention to how SGH’s Crux stake could influence the company’s long-term energy exposure and portfolio mix within its broader infrastructure and resources footprint. We’ll now explore how this renewed focus on...

Some Super Retail Group Limited ( ASX:SUL ) shareholders may be a little concerned to see that insider Reginald Rowe...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Macquarie Group’s move to build a 5% holding in Downer EDI (ASX:DOW), alongside the company’s ongoing on market share buy back, has drawn fresh attention to how investors assess this infrastructure services stock. See our latest analysis for Downer EDI. Macquarie’s 5% stake and the ongoing buy back come at a time when the share price has slipped since the start of the year, with a year to date share price return of a 5.26% decline. However, a 3 year total shareholder return of 137.35%...

Even if it's not a huge purchase, we think it was good to see that Neville Power, the Independent Non-Executive Deputy...

The recent 11% drop in AdNeo Limited's ( ASX:AD1 ) stock could come as a blow to insiders who purchased AU$365.1k worth...

Smartgroup Corporation Ltd (ASX:SIQ) has approved a share repurchase program, authorizing up to A$20,000,000 of ordinary shares to be bought back from existing cash reserves, including proceeds from the earlier sale of its self-funded fleet portfolio. This move effectively reallocates surplus capital back to shareholders and may modestly reduce the current base of 137,398,556 issued shares, altering future per-share metrics. We’ll now examine how this A$20,000,000 buyback authorization could...

Anglo American has agreed to sell its Queensland coking coal mines for up to US$5.40 billion to Dhilmar Limited, a private British company linked to ASX-listed mining services provider Macmahon Holdings, including stakes in the Grosvenor, Moranbah North, Dawson, Aquila and Capcoal operations. This transaction potentially deepens Macmahon’s commercial alignment with major metallurgical coal assets, raising questions about future contract opportunities, capital commitments, and concentration...

As the Australian market faces a cautious opening with expectations of a 20-point drop, driven by concerns over rising U.S. bond yields and potential price pressures in the economy, investors are keenly observing opportunities amidst these fluctuations. In such conditions, identifying undervalued stocks can be crucial for those looking to capitalize on potential growth, especially when market sentiment suggests caution.

Australian shares are expected to open lower, reflecting cautious sentiment from Wall Street as U.S. bond yields reach levels not seen since before the 2007 financial crisis. In this climate of economic uncertainty and rising price pressures, investors may consider exploring penny stocks—an investment area that continues to hold relevance despite its somewhat outdated name. These smaller or newer companies can offer surprising value and potential growth, particularly when they demonstrate...

In May 2026, Pro Medicus announced it had signed a seven-year, A$90 million contract with Boston-based Beth Israel Lahey Health to roll out its Visage 7 cloud imaging platform across 14 hospitals, with an initial go-live targeted for early 2027. An interesting aspect of this deal is its transaction-based licensing model, which ties Pro Medicus’s revenue to Beth Israel Lahey Health’s actual imaging volumes over the contract term. We’ll now examine how this large, transaction-based US hospital...

Ramelius Resources (ASX:RMS) has drawn fresh attention after the stock fell alongside broader materials sector weakness, with technical traders highlighting a Head & Shoulders pattern that has increased concern about potential downside risk. See our latest analysis for Ramelius Resources. At the current A$3.07 share price, Ramelius has seen short term share price momentum fade, with the share price down 4.66% over 1 day, 14.25% over 7 days and 23.25% over 30 days. However, longer term total...

Earlier this month, Orica Limited reported half-year results showing sales of A$3,884.2 million and a net loss of A$0.6 million, while also declaring an unfranked ordinary dividend of A$0.285 per share for the six months to March 31, 2026. Interestingly, this dividend comes despite the company remaining loss-making over the half year, although the loss narrowed substantially compared with the prior period. With Orica’s latest dividend declaration arriving alongside a sharply reduced net...

Abacus Storage King has announced binding agreements to internalise its management platform and, subject to shareholder approval, rebrand as Storage King Group with the ASX ticker SKG from 30 June 2026, aiming to lift Funds from Operations per security by about 6% through cost savings and executive retention. This move effectively aligns the operating platform and capital structure under a single listed entity, potentially sharpening accountability and operational focus across its Australia...

Recent commentary has highlighted Telstra Group as a high-yield ASX dividend stock, with analysts projecting a meaningful uplift in its 2026 financial year dividend, reinforcing its perceived resilience as Australia's leading telecommunications provider. This focus on Telstra's potential for dividend income growth that may outpace inflation underscores how investors are weighing its pricing power and role in supporting long-term digital demand. Next, we’ll examine how the anticipated...

CSL recently reported that its first Canadian patient has received HEMGENIX® for hemophilia B at London Health Sciences Centre, following public reimbursement agreements that now provide access in Ontario and British Columbia while other provinces review coverage. This early real-world use of HEMGENIX® under public funding in Canada highlights how CSL’s high-value gene therapy portfolio is beginning to translate into tangible patient access and market uptake. Next, we’ll examine how this...

In recent months, Bank of Queensland has come under pressure as intense mortgage competition and higher wholesale funding costs have squeezed its net interest margins and raised concerns about its operational outlook. Beyond these margin headwinds, the bank’s large-scale digital transformation and broader economic uncertainty are heightening execution and credit risks at a time when its business model is already under strain. We’ll now examine how sustained margin pressure from rising...

Recent share performance snapshot James Hardie Industries (ASX:JHX) has been under pressure recently, with the stock down 0.9% over the past day, 4.7% over the past week and about 11.6% over the past month. Looking over a longer horizon, the share price has fallen roughly 25.4% over the past 3 months, is down 13.8% year to date and has declined about 26.5% over the past year. See our latest analysis for James Hardie Industries. With the share price at A$26.55 and recent declines over both the...

TPG Telecom recently confirmed it met its goal in December 2025 of matching 100% of its operational electricity use with renewable electricity supplied to the grid, supported by long-term power purchase agreements and renewable energy certificates across mobile towers, retail stores and offices. This marks a key milestone in TPG Telecom’s net zero emissions plan and may influence how investors assess its environmental and operational profile. We’ll now explore how TPG Telecom’s full...

In May 2026, Alkane Resources reported third-quarter results showing A$274.37 million in sales and A$92.99 million in net income, alongside materially higher earnings per share versus a year earlier. At the same time, Alkane issued full-year 2026 production guidance for 149,000–161,000 ounces of gold and 155,000–168,000 gold-equivalent ounces, giving investors clearer visibility on expected output across its operations. We’ll now examine how Alkane’s sharply higher quarterly earnings and...

Westpac Banking (ASX:WBC) is back in focus after tightening lending criteria for negatively geared property investors following federal budget changes, a policy shift that could influence housing activity and sentiment toward the stock. See our latest analysis for Westpac Banking. The share price has been under pressure recently, with a 30 day share price return down 11.27% and a 90 day share price return down 15.23%. However, the 1 year total shareholder return of 16.97% and 3 year total...

Metcash guidance and special call: what changed Metcash (ASX:MTS) has issued unaudited earnings guidance for the fiscal year ended April 30, 2026, flagging estimated group revenue of A$19.6b and group EBIT of A$501 million to A$505 million. See our latest analysis for Metcash. Metcash’s latest guidance and special call come after a mixed run for the stock, with a 30 day share price return of 3.45% but a year to date share price decline of 9.37%. The 5 year total shareholder return of 9.95%...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

With the business potentially at an important milestone, we thought we'd take a closer look at Zeotech Limited's...